Jefferies Financial Group Inc. grew its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 35.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,557 shares of the semiconductor company's stock after acquiring an additional 665 shares during the period. Jefferies Financial Group Inc.'s holdings in Synopsys were worth $1,241,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of the stock. Advisors Capital Management LLC increased its stake in shares of Synopsys by 2.3% during the fourth quarter. Advisors Capital Management LLC now owns 840 shares of the semiconductor company's stock worth $408,000 after purchasing an additional 19 shares in the last quarter. Caprock Group LLC grew its stake in Synopsys by 0.5% during the 4th quarter. Caprock Group LLC now owns 3,714 shares of the semiconductor company's stock valued at $1,803,000 after acquiring an additional 20 shares in the last quarter. Compagnie Lombard Odier SCmA grew its stake in Synopsys by 1.1% during the 4th quarter. Compagnie Lombard Odier SCmA now owns 1,850 shares of the semiconductor company's stock valued at $898,000 after acquiring an additional 20 shares in the last quarter. Edge Capital Group LLC grew its stake in Synopsys by 1.2% during the 4th quarter. Edge Capital Group LLC now owns 1,629 shares of the semiconductor company's stock valued at $791,000 after acquiring an additional 20 shares in the last quarter. Finally, Barden Capital Management Inc. grew its stake in Synopsys by 1.1% during the 4th quarter. Barden Capital Management Inc. now owns 1,832 shares of the semiconductor company's stock valued at $889,000 after acquiring an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.
Synopsys Stock Up 1.1%
Shares of NASDAQ:SNPS traded up $5.09 during trading on Friday, reaching $460.08. The stock had a trading volume of 3,356,054 shares, compared to its average volume of 1,143,651. The business has a fifty day moving average price of $453.46 and a 200-day moving average price of $486.08. The stock has a market cap of $71.14 billion, a P/E ratio of 31.69, a PEG ratio of 3.23 and a beta of 1.16. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $624.80.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.40 by $0.27. Synopsys had a net margin of 36.12% and a return on equity of 20.48%. The firm had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.60 billion. During the same period in the previous year, the firm earned $3.00 earnings per share. Synopsys's revenue was up 10.3% compared to the same quarter last year. As a group, equities analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.
Insider Activity at Synopsys
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the sale, the chief executive officer now directly owns 70,922 shares in the company, valued at $32,890,077.50. The trade was a 13.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Geus Aart De sold 15,705 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the sale, the insider now owns 116,671 shares of the company's stock, valued at approximately $51,850,925.82. This represents a 11.86% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the stock. Mizuho dropped their price target on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating for the company in a research note on Tuesday, April 15th. Rosenblatt Securities dropped their price target on shares of Synopsys from $660.00 to $625.00 and set a "buy" rating for the company in a research note on Thursday. Stifel Nicolaus set a $550.00 price target on shares of Synopsys in a research note on Monday, April 28th. Bank of America dropped their price target on shares of Synopsys from $630.00 to $560.00 and set a "buy" rating for the company in a research note on Wednesday, April 16th. Finally, Needham & Company LLC restated a "buy" rating and issued a $650.00 price objective on shares of Synopsys in a report on Thursday. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $609.64.
Check Out Our Latest Stock Report on SNPS
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.